Patents by Inventor Aurelio Marsiglio

Aurelio Marsiglio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic combination comprising a CDKS inhibitor and an antineoplastic agent
    Patent number: 8518930
    Abstract: The present invention provides a therapeutic combination comprising (a) a compound of formula (I) as set forth in the specification and (b) one or more antineoplastic agents selected from the group consisting of alkylating or alkylating-like agents, antimetabolite agents and topoisomerase I inhibitors, wherein the active ingredients are present in each case in free form or in the form of a pharmaceutically acceptable salt or any hydrate thereof.
    Type: Grant
    Filed: July 29, 2009
    Date of Patent: August 27, 2013
    Assignee: Nerviano Medical Sciences S.r.l.
    Inventors: Marina Ciomei, Aurelio Marsiglio, Valter Domenico Croci, Enrico Pesenti
  • THERAPEUTIC COMBINATION COMPRISING A CDKS INHIBITOR AND AN ANTINEOPLASTIC AGENT
    Publication number: 20110312909
    Abstract: The present invention provides a therapeutic combination comprising (a) a compound of formula (I) as set forth in the specification and (b) one or more antineoplastic agents selected from the group consisting of alkylating or alkylating-like agents, antimetabolite agents and topoisomerase I inhibitors, wherein the active ingredients are present in each case in free form or in the form of a pharmaceutically acceptable salt or any hydrate thereof.
    Type: Application
    Filed: July 29, 2009
    Publication date: December 22, 2011
    Applicant: Nerviano Medical Sciences S.r.l.
    Inventors: Marina Ciomei, Aurelio Marsiglio, Valter Domenico Croci, Enrico Pesenti
  • MORPHOLINYL ANTHRACYCLINE DERIVATIVE COMBINED WITH PROTEIN KINASE INHIBITORS
    Publication number: 20100190736
    Abstract: The present invention provides the combined use of a morpholinyl anthracycline derivative of formula (I) as defined in the specification or a pharmaceutically acceptable salt thereof, such as nemorubicin hydrochloride, and a protein kinase (PK) inhibitor, in the treatment of tumors. Also provided is the use of the said combinations in the treatment or prevention of metastasis or in the treatment of tumors by inhibition of angiogenesis.
    Type: Application
    Filed: July 23, 2008
    Publication date: July 29, 2010
    Applicant: NERVIANO MEDICAL SCIENCES S.R.L.
    Inventors: Maria Cristina Geroni, Olga Valota, Dario Ballinari, Aurelio Marsiglio